Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Microb Pathog ; 119: 65-71, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29649517

RESUMO

The effects of nisin on the neurochemicals, Aquaporin-3 (AQP-3) and intestinal microorganisms in the brain-gut axis of mice were analyzed by using enzyme linked immune sorbent assay (ELISA) and high throughput sequencing in this investigation, to further revealed the relationship between intestinal flora abundance in mice and neurochemicals in the brain-gut axis. Using HE staining found damage of structure of small intestine villi in the model group (Escherichia coli O1, E. coli O1). Compared with normal control and ciprofloxacin groups, using ELISA showed that nisin increased the highest norepinephrine (NE) expression in the brain, expression of 5-hydroxytryptamine (5-HT) and dopamine (DA) in the duodenum, and increased the expression of AQP-3 in jejunum. Using high-throughput sequencing showed the highest diversity of cecal microflora in nisin group (ACE-index = 1417.25, Chao1-index = 1378.45), but the cecal microflora in the negative control group (ACE-index = 969.54, Chao1-index = 340.29) exhibited the lowest species diversity. Our data indicated that nisin regulates neurochemicals, AQP-3 and cecal microflora imbalance in mice.


Assuntos
Encéfalo/efeitos dos fármacos , Diarreia/metabolismo , Diarreia/microbiologia , Escherichia coli/patogenicidade , Microbioma Gastrointestinal/efeitos dos fármacos , Nisina/farmacologia , Animais , Aquaporina 3/sangue , Aquaporina 3/efeitos dos fármacos , Biodiversidade , Ceco/efeitos dos fármacos , Ceco/microbiologia , Ceco/patologia , DNA Bacteriano/análise , Dopamina/sangue , Dopamina/farmacologia , Duodeno/metabolismo , Duodeno/patologia , Íleo/metabolismo , Íleo/patologia , Mucosa Intestinal/metabolismo , Jejuno/metabolismo , Jejuno/patologia , Masculino , Camundongos , Norepinefrina/sangue , Norepinefrina/farmacologia , Serotonina/sangue , Serotonina/metabolismo
2.
Reprod Domest Anim ; 52(5): 825-835, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28512855

RESUMO

The objective of our present study was to determine the effects of insulin-like growth factor I (IGF-I) on the development of yak (Bos grunniens) embryos after cumulus-oocyte complex (COC) vitrification and warming followed by in vitro fertilization (IVF). In Experiment 1, the yak COCs underwent vitrification and then IVF. Embryos were incubated in synthetic oviductal fluid (SOF) supplemented with four concentrations (0, 50, 100 and 200 ng/ml) of IGF-I, while the yak COCs without vitrification or IGF-I supplementation acted as the control group; the BAX, BCL-2, AQP3mRNA and aquaporin 3 (AQP3) protein expression levels in the five groups of blastocysts were evaluated using quantitative real-time PCR and immunofluorescence analyses. In Experiment 2, the groups described above were fertilized and incubated. The cleavage rate, blastocyst rate, total cell count per blastocyst and the rate of growth of the inner cell mass (ICM) and trophectoderm (TE) were evaluated. The results were as follows: (1) the AQP3 gene expression and protein expression in the control and 100 ng/ml IGF-I treatment groups were the highest. (2) The BAX gene expression was the lowest and the BCL-2 gene expression was the highest in the control and 100 ng/ml IGF-I treatment groups. (3) The rates of cleavage and blastocysts in the control and 100 ng/ml IGF-I groups were higher than those in the other three groups. The total cell count per blastocyst in the vitrified and warmed 100 ng/ml IGF-I group (106.7 ± 4.9) and the control group (107.3 ± 4.2) was higher than that in the vitrified and warmed 0 ng/ml IGF-I (91.2 ± 3.1), 50 ng/ml IGF-I (92.3 ± 3.7) and 200 ng/ml IGF-I (92.4 ± 3.7) groups. Therefore, we conclude that IGF-I can improve yak blastocyst developmental ability, cytomembrane permeability and formation of the blastocyst cavity after COC vitrification by improving the BAX, BCL-2 and AQP3 expression levels.


Assuntos
Aquaporina 3/efeitos dos fármacos , Bovinos , Fator de Crescimento Insulin-Like I/farmacologia , Animais , Aquaporina 3/metabolismo , Blastocisto/fisiologia , Técnicas de Cultura Embrionária , Desenvolvimento Embrionário/efeitos dos fármacos , Feminino , Fertilização in vitro , Expressão Gênica , Genes bcl-2 , Fator de Crescimento Insulin-Like I/administração & dosagem , Masculino , Oócitos/efeitos dos fármacos , Oócitos/fisiologia , Vitrificação
3.
J Invest Dermatol ; 137(9): 1935-1944, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28526298

RESUMO

Aquaporin- (AQP) 3, a water and glycerol channel, plays an important role in epidermal function, with studies showing its involvement in keratinocyte proliferation, differentiation, and migration and in epidermal wound healing and barrier repair. Increasing speculation about the use of histone deacetylase (HDAC) inhibitors to treat skin diseases led us to investigate HDAC's role in the regulation of AQP3. The broad-spectrum HDAC inhibitor suberoylanilide hydroxamic acid induced AQP3 mRNA and protein expression in a dose- and time-dependent manner in normal keratinocytes. The SAHA-induced increase in AQP3 levels resulted in enhanced [3H]glycerol uptake in normal but not in AQP3-knockout keratinocytes, confirming that the expressed AQP3 was functional. Use of HDAC inhibitors with different specificities limited our exploration of the responsible HDAC member to HDAC1, HDAC2, or HDAC3. Cre-recombinase-mediated knockdown and overexpression of HDAC3 suggested a role for HDAC3 in suppressing AQP3 expression basally. Further investigation implicated p53 as a transcription factor involved in regulating HDAC inhibitor-induced AQP3 expression. Thus, our study supports the regulation of AQP3 expression by HDAC3 and p53. Because suberoylanilide hydroxamic acid is already approved to treat cutaneous T-cell lymphoma, it could potentially be used as a therapy for skin diseases like psoriasis, where AQP3 is abnormally expressed.


Assuntos
Aquaporina 3/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Glicerol/metabolismo , Histona Desacetilases/farmacologia , Queratinócitos/metabolismo , Animais , Animais Recém-Nascidos , Aquaporina 3/metabolismo , Transporte Biológico/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Proliferação de Células/fisiologia , Células Cultivadas , Epiderme/metabolismo , Humanos , Técnicas In Vitro , Queratinócitos/citologia , Camundongos , Camundongos Knockout , Sensibilidade e Especificidade , Proteína Supressora de Tumor p53/metabolismo
4.
World J Gastroenterol ; 21(15): 4547-54, 2015 Apr 21.
Artigo em Inglês | MEDLINE | ID: mdl-25914463

RESUMO

AIM: To investigate the influence of lipopolysaccharide (LPS) through the p38/c-Jun N-terminal kinase (JNK) signalling pathway on aquaporin 3 (AQP3) expression in HT-29 human colon epithelial cells. METHODS: HT-29 cells were treated with LPS, and then the membrane localisation of AQP3 was examined by immunofluorescence staining. The mRNA and protein expression of AQP3 with LPS exposure was measured by real-time reverse transcription-PCR and Western blot, respectively. Activation of p38 and JNK was evaluated by detection of phosphorylation of p38 and JNK using Western blot assay. AQP3 protein expression was determined by Western blot in cells after treatment with SB203580, a selective p38 MAPK inhibitor, or SP600125, a selective JNK inhibitor. RESULTS: In HT-29 cells, the transcription and protein expression of AQP3 were decreased by LPS in a dose- and time-dependent manner, the expression of AQP3 was significantly decreased with the increased concentration of LPS, and at a dose of 100 µg/mL LPS, AQP3 mRNA and protein levels were decreased by a maximum (P < 0.05) of 1.51-fold and 1.49-fold, respectively. When cells were treated with 100 µg/mL LPS for 0, 3, 6, 12, and 24 h, the AQP3 mRNA level was significantly decreased at an early time point of 3 h, and reached about 10% of the control level at 24 h post-treatment (P < 0.05). Down-regulation of AQP3 expression was significantly inhibited by the p38 inhibitor (SB203580) and JNK inhibitor (SP600125). CONCLUSION: p38 and JNK may be promising targets for the preservation of AQP3 expression and may be beneficial to the clinical management of diarrhoea.


Assuntos
Aquaporina 3/efeitos dos fármacos , Colo/efeitos dos fármacos , Células Epiteliais/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Lipopolissacarídeos/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo , Antidiarreicos/farmacologia , Aquaporina 3/genética , Aquaporina 3/metabolismo , Colo/enzimologia , Relação Dose-Resposta a Droga , Regulação para Baixo , Ativação Enzimática , Células Epiteliais/enzimologia , Células HT29 , Humanos , Mucosa Intestinal/enzimologia , Proteínas Quinases JNK Ativadas por Mitógeno/antagonistas & inibidores , Fosforilação , Inibidores de Proteínas Quinases/farmacologia , RNA Mensageiro/metabolismo , Transdução de Sinais/efeitos dos fármacos , Fatores de Tempo , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores
5.
Arch Pharm Res ; 38(8): 1552-60, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25269537

RESUMO

Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid (ω-3 PUFA) that protects against photodamage and photocarcinogenesis in mammals. Aquaporin-3 (AQP3) is a water/glycerol transport protein that is found in basal layer keratinocytes. In this study, we have investigated the protective effect of EPA against ultraviolet B (UVB)-induced AQP3 downregulation in human keratinocytes. EPA treatment was found to increase AQP3 gene and protein expression in human epidermal keratinocytes (HaCaT). Using a specific inhibitor, we observed that the effect of EPA on AQP3 expression was mediated by extracellular signal-regulated kinase (ERK) activation. UVB radiation induced AQP3 downregulation in HaCaT cells, and it was found that EPA treatment attenuated UVB-induced AQP3 reduction and the associated cell death. UVB-induced downregulation of AQP3 was blocked by EPA and p38 inhibitor SB203580. Collectively, the present results show that EPA increased AQP3 expression and that this led to a reduction UVB-induced photodamage.


Assuntos
Aquaporina 3/efeitos dos fármacos , Aquaporina 3/efeitos da radiação , Ácido Eicosapentaenoico/farmacologia , Queratinócitos/efeitos dos fármacos , Queratinócitos/efeitos da radiação , Raios Ultravioleta/efeitos adversos , Animais , Aquaporina 3/metabolismo , Proliferação de Células/efeitos dos fármacos , Proliferação de Células/fisiologia , Células Cultivadas , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/fisiologia , Regulação para Baixo/efeitos da radiação , Feminino , Humanos , Queratinócitos/metabolismo , Camundongos , Camundongos Pelados
6.
Pflugers Arch ; 467(9): 1931-43, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25339224

RESUMO

Menière's disease, clinically characterized by fluctuating, recurrent, and invalidating vertigo, hearing loss, and tinnitus, is linked to an increase in endolymph volume, the so-called endolymphatic hydrops. Since dysregulation of water transport could account for the generation of this hydrops, we investigated the role of aquaporin 3 (AQP3) in water transport into endolymph, the K-rich, hyperosmotic fluid that bathes the apical ciliated membrane of sensory cells, and we studied the regulatory effect of dexamethasone upon AQP3 expression and water fluxes. The different AQP subtypes were identified in inner ear by RT-PCR. AQP3 was localized in human utricle and mouse inner ear by immunohistochemistry and confocal microscopy. Unidirectional transepithelial water fluxes were studied by means of (3)H2O transport in murine EC5v vestibular cells cultured on filters, treated or not with dexamethasone (10(-7) M). The stimulatory effect of dexamethasone upon AQP3 expression was assessed in EC5v cells and in vivo in mice. AQP3 was unambiguously detected in human utricle and was highly expressed in both endolymph secretory structures of the mouse inner ear, and EC5v cells. We demonstrated that water reabsorption, from the apical (endolymphatic) to the basolateral (perilymphatic) compartments, was stimulated by dexamethasone in EC5v cells. This was accompanied by a glucocorticoid-dependent increase in AQP3 expression at both messenger RNA (mRNA) and protein level, presumably through glucocorticoid receptor-mediated AQP3 transcriptional activation. We show that glucocorticoids enhance AQP3 expression in human inner ear and stimulate endolymphatic water reabsorption. These findings should encourage further clinical trials evaluating glucocorticoids efficacy in Menière's disease.


Assuntos
Aquaporina 3/biossíntese , Orelha Interna/efeitos dos fármacos , Endolinfa/metabolismo , Glucocorticoides/farmacologia , Água/metabolismo , Adsorção , Animais , Aquaporina 3/efeitos dos fármacos , Western Blotting , Células Cultivadas , Dexametasona/farmacologia , Orelha Interna/metabolismo , Endolinfa/efeitos dos fármacos , Humanos , Imuno-Histoquímica , Camundongos , Microscopia Confocal , Reação em Cadeia da Polimerase Via Transcriptase Reversa
7.
Am J Physiol Renal Physiol ; 305(10): F1491-7, 2013 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-24005472

RESUMO

Thiazolidinediones (TZDs), which are synthetic peroxisome proliferator-activated receptor subtype-γ (PPARγ), agonists are highly effective for treatment of type 2 diabetes. However, the side effect of fluid retention has significantly limited their application. Most of the previous studies addressing TZD-induced fluid retention employed healthy animals. The underlying mechanism of this phenomenon is still incompletely understood, particularly in the setting of disease state. The present study was undertaken to examine rosiglitazone (RGZ)-induced fluid retention in db/db mice and to further investigate the underlying mechanism. In response to RGZ treatment, db/db mice exhibited an accelerated plasma volume expansion as assessed by hematocrit (Hct) and fluorescent nanoparticles, in parallel with a greater increase in body weight, compared with lean controls. In response to RGZ-induced fluid retention, urinary Na(+) excretion and urine volume were significantly increased in lean mice. In contrast, the natriuretic and diuretic responses were significantly blunted in db/db mice. RGZ db/db mice exhibited a parallel decrease in plasma Na(+) concentration and plasma osmolality, contrasting to unchanged levels in lean controls. Imunoblotting analysis showed downregulation of renal aquaporin (AQP) 2 expression in response to RGZ treatment in lean mice but not in db/db mice. Renal AQP3 protein expression was unaffected by RGZ treatment in lean mice but was elevated in db/db mice. In contrast, the expression of Na(+)/H(+) exchanger-3 (NHE3) and NKCC2 was unchanged in either mouse strain. Together these results suggest that compared with the lean controls, db/db mice exhibited accelerated plasma volume expansion that was in part due to the inappropriate response of renal water transporters.


Assuntos
Água Corporal/metabolismo , Diabetes Mellitus/tratamento farmacológico , Hipoglicemiantes/toxicidade , Rim/efeitos dos fármacos , Volume Plasmático/efeitos dos fármacos , Tiazolidinedionas/toxicidade , Equilíbrio Hidroeletrolítico/efeitos dos fármacos , Desequilíbrio Hidroeletrolítico/induzido quimicamente , Animais , Aquaporina 2/efeitos dos fármacos , Aquaporina 2/metabolismo , Aquaporina 3/efeitos dos fármacos , Aquaporina 3/metabolismo , Transporte Biológico , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Diabetes Mellitus/sangue , Modelos Animais de Doenças , Diurese/efeitos dos fármacos , Humanos , Rim/metabolismo , Masculino , Camundongos , Natriurese/efeitos dos fármacos , Concentração Osmolar , PPAR gama/agonistas , PPAR gama/metabolismo , Rosiglitazona , Trocador 3 de Sódio-Hidrogênio , Trocadores de Sódio-Hidrogênio/metabolismo , Membro 1 da Família 12 de Carreador de Soluto/metabolismo , Triglicerídeos/sangue , Desequilíbrio Hidroeletrolítico/sangue , Aumento de Peso/efeitos dos fármacos
8.
Asian Pac J Trop Med ; 5(2): 107-9, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22221751

RESUMO

OBJECTIVE: To analyze the structure of aquaporins-3(AQP-3) from Schistosoma japonicum(SJAQP-3) using bioinformatical methods, and to provid of references for vaccine targets research. METHODS: Protparam, BepiPred, TMHMM Server, MLRC, Geno3d, DNA star software packages were used to predict the physical and chemical properties, hydrophilicity plot, flexibility regions, antigenic index, surface probability plot, secondary structure, and tertiary structure of amino acid sequence of SJAQP-3. RESULTS: SJAQP-3 had six transmembrane regions and two half-spanning helices that form a central channel. The half-spanning helices fold into the centre of the channel. Either of the half-spanning helix had a conserved motif of NPA common to all aquaporins. Predicted linear B-Cell epitopes were most likely at the N-terminal amino acid residues of 5aa-7aa, 59aa-62aa, 225aa-230aa, 282aa -288aa, 294aa -298aa and 305aa -307aa area. 59aa- 62aa, 225aa-230aa located outside the membrane, the others located inside the cell. CONCLUSIONS: SJAQP-3 is a integral membrane protein in Schistosoma japonicum tegument. There are six potential epitopes in SJAQP-3. It might be a potential molecular target for the development of vaccines.


Assuntos
Aquaporina 3/imunologia , Biologia Computacional , Epitopos de Linfócito B/imunologia , Schistosoma japonicum/imunologia , Esquistossomose Japônica/prevenção & controle , Sequência de Aminoácidos , Animais , Aquaporina 3/efeitos dos fármacos , Epitopos de Linfócito B/efeitos dos fármacos , Humanos , Modelos Moleculares , Schistosoma japonicum/efeitos dos fármacos , Schistosoma japonicum/genética , Esquistossomose Japônica/imunologia , Vacinação
9.
J Ethnopharmacol ; 139(2): 409-13, 2012 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-22138657

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: We have previously reported that Byakkokaninjinto improves cutaneous pruritus by increasing the expression level of aquaporin-3 (AQP3). In this study, we examined the effect of Gypsum fibrosum (main component: CaSO(4)), which is the main component of Byakkokaninjinto, on the cutaneous AQP3 expression level. MATERIALS AND METHODS: KKAy mice were given a diet containing 0.3% Gypsum fibrosum extract, or a diet containing 0.3% CaSO(4) for 4 weeks. The urine volume, plasma glucose levels, cutaneous AQP3 protein expression, and the Ca(2+) content were measured. RESULTS: The 24-h urine volumes and the plasma glucose levels in the Gypsum fibrosum extract group were not significantly different from those in the control group. In the Gypsum fibrosum extract group, the cutaneous AQP3 protein levels increased significantly, by approximately 3.2-fold, compared to the control group. The cutaneous Ca(2+) content in the control group was approximately 35µg/g. In the Gypsum fibrosum extract group, the Ca(2+) content increased to approximately 51µg/g, which was significant compared to the control group. In the CaSO(4) group, an increase in the AQP3 protein expression levels and Ca(2+) content were observed; the extent of these increases were similar to those in the Gypsum fibrosum extract group. CONCLUSIONS: The results of this study suggest that Gypsum fibrosum plays an important role in the increased levels of cutaneous AQP3 expression enhanced by Byakkokaninjinto. The results also indicate that the increase in AQP3 caused by Gypsum fibrosum is attributable to an increase in the cutaneous Ca(2+) content from its main component, CaSO(4).


Assuntos
Antipruriginosos/farmacologia , Aquaporina 3/efeitos dos fármacos , Sulfato de Cálcio/farmacologia , Medicamentos de Ervas Chinesas/farmacologia , Pele/efeitos dos fármacos , Animais , Antipruriginosos/química , Aquaporina 3/genética , Aquaporina 3/metabolismo , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Sulfato de Cálcio/análise , Medicamentos de Ervas Chinesas/química , Camundongos , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Pele/metabolismo , Regulação para Cima , Urodinâmica/efeitos dos fármacos
10.
Respir Physiol Neurobiol ; 161(2): 111-8, 2008 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-18280225

RESUMO

Aquaporins (AQPs) are membrane channel proteins that play roles in the regulation of water permeability in many tissues. AQP1 and AQP5 expressed in lung provide the principal route for osmotically driven water transport. In the airways, AQP3 and AQP4 facilitate water transport. Dexamethasone and ambroxol are often used to treat patients with pulmonary diseases accompanied by airway hypersecretion. The role of AQPs in these effective treatments has not been addressed. In this study, we analyzed the expression of AQPs in a human airway epithelial cell line (A549 cells) and showed that AQP3 and 5, but not AQP1 and 4, were expressed in A549 cells. Both dexamethasone and ambroxol stimulated the expression of AQP3 and 5 at the mRNA and protein levels. The data suggest potential roles of AQP3 and 5 in the regulation of airway hypersecretion, perhaps ultimately providing a target for treating such diseases.


Assuntos
Adenocarcinoma/metabolismo , Aquaporina 3/metabolismo , Aquaporina 5/metabolismo , Células Epiteliais/metabolismo , Neoplasias Pulmonares/metabolismo , Adenocarcinoma/tratamento farmacológico , Ambroxol/farmacologia , Aquaporina 1/efeitos dos fármacos , Aquaporina 1/genética , Aquaporina 1/metabolismo , Aquaporina 3/efeitos dos fármacos , Aquaporina 3/genética , Aquaporina 4/efeitos dos fármacos , Aquaporina 4/genética , Aquaporina 4/metabolismo , Aquaporina 5/efeitos dos fármacos , Aquaporina 5/genética , Dexametasona/farmacologia , Células Epiteliais/citologia , Células Epiteliais/efeitos dos fármacos , Expectorantes/farmacologia , Humanos , Imuno-Histoquímica , Neoplasias Pulmonares/tratamento farmacológico , RNA Mensageiro/análise , Mucosa Respiratória/citologia , Mucosa Respiratória/efeitos dos fármacos , Mucosa Respiratória/metabolismo , Células Tumorais Cultivadas
11.
Aquat Toxicol ; 82(2): 85-93, 2007 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-17367878

RESUMO

The effects of nitrite, at varying concentrations (0, 25 and 50mg/l), on silver sea bream (Sparus sarba), was assessed after 7 days exposure. Nitrite exposure resulted in an elevated renosomatic index in parallel with increased kidney water content. Measurements of serum thyroid hormones demonstrated that levels of thyroxine (T(4)) were decreased upon nitrite exposure whereas triiodothyronine (T(3)) concentrations remained unchanged. Nitrite did not affect serum K and Na levels but did cause an increase in gill sodium pump (Na(+)-K(+)-ATPase) activity. Using immunoassays, it was found that the abundance of the water channel protein, aquaporin 3 (AQP3) was unchanged in gills but decreased in kidneys of sea bream upon nitrite exposure. Immunoassay analysis also demonstrated that the amount of the heat shock protein 70 (HSP70) family were increased in gills, kidney and liver during nitrite exposure whereas amounts of the heat shock protein 90 (HSP90) family increased in kidneys and liver. Taken together, the findings from this study provide new insights into how nitrite affects osmoregulatory, endocrine processes and heat shock protein expression in a marine fish.


Assuntos
Citoproteção/efeitos dos fármacos , Sistema Endócrino/efeitos dos fármacos , Nitritos/toxicidade , Perciformes/fisiologia , Poluentes Químicos da Água/toxicidade , Equilíbrio Hidroeletrolítico/efeitos dos fármacos , Animais , Aquaporina 3/análise , Aquaporina 3/efeitos dos fármacos , Expressão Gênica/efeitos dos fármacos , Brânquias/efeitos dos fármacos , Brânquias/enzimologia , Proteínas de Choque Térmico/análise , Rim/efeitos dos fármacos , Rim/enzimologia , Fígado/química , Fígado/efeitos dos fármacos , Potássio/sangue , Distribuição Aleatória , Sódio/sangue , ATPase Trocadora de Sódio-Potássio/efeitos dos fármacos , Glândula Tireoide/efeitos dos fármacos , Tiroxina/sangue , Tri-Iodotironina/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...